Trexquant Investment’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-592,877	Closed	-$7.2M	–	1979
2025 Q4	$7.2M	Buy	592,877 +405,095	+216%	+$4.92M	0.06%	425
2025 Q3	$2.2M	Buy	+187,782	New	+$2.25M	0.02%	877
2022 Q2	–	Sell	-71,224	Closed	-$353K	–	1756
2022 Q1	$353K	Buy	+71,224	New	+$395K	0.02%	924
2021 Q4	–	Sell	-36,840	Closed	-$368K	–	1534
2021 Q3	$368K	Buy	36,840 +20,554	+126%	+$231K	0.03%	658
2021 Q2	$231K	Sell	16,286 -14,977	-48%	-$228K	0.02%	839
2021 Q1	$513K	Buy	+31,263	New	+$602K	0.05%	498
2020 Q4	–	Sell	-32,791	Closed	-$250K	–	1362
2020 Q3	$250K	Buy	32,791 +20,539	+168%	+$170K	0.02%	1002
2020 Q2	$102K	Buy	+12,252	New	+$81.2K	0.01%	1114
2018 Q4	–	Sell	-20,190	Closed	-$139K	–	1233
2018 Q3	$139K	Buy	+20,190	New	+$127K	0.01%	875
2017 Q1	–	Sell	-21,663	Closed	-$181K	–	1247
2016 Q4	$181K	Buy	+21,663	New	+$168K	0.03%	850
2016 Q1	–	Sell	-13,731	Closed	-$129K	–	1097
2015 Q4	$129K	Buy	13,731 +2,959	+27%	+$31.9K	0.01%	963
2015 Q3	$151K	Sell	10,772 -4,928	-31%	-$99K	0.01%	988
2015 Q2	$329K	Buy	15,700 +6,352	+68%	+$157K	0.04%	782
2015 Q1	$392K	Buy	+9,348	New	+$307K	0.04%	777